A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.